Cardiopulmonary diseases remain a leading cause of global morbidity and mortality, with environmental exposures playing a pivotal role in their ...

While many people do feel symptoms—a rapid heartbeat, skipping a beat, dizziness, extreme shortness of breath—up to a third of those with AFib don’t realize they have it, either because they have no ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Abbott Laboratories’ (NYSE: ABT) Volt PFA System to treat patients battling atrial fibrillation (AFib). AFib is the most common type of ...

Atrial fibrillation (AFib) is a heart condition that can affect even the fittest individuals, often presenting without obvious symptoms. As a dedicated cyclist in good health, I was surprised by my ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an international ...

Over 5 million Americans have atrial fibrillation, or AFib, an arrhythmia heart disorder in which the heart’s upper chambers (the atria) beat out of synch with the lower chambers, causing an irregular ...